Sabato 27 ottobre 2012 - Pacini Editore
Sabato 27 ottobre 2012 - Pacini Editore
Sabato 27 ottobre 2012 - Pacini Editore
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
354<br />
Fig. 3. Microscopic appearance of ameloblastic carcinoma. tumor<br />
islands with focal features of ameloblastoma (a) and areas with<br />
obvious malignant aspects as spindle cells, pleomorphism and hyperchromatism,<br />
increased mitotic ratio (B, C, d)..<br />
We present a case of a 15-year old man who was diagnosed, by<br />
occasional OPT, with a large expansive mass at right maxilla.<br />
CT scan demonstrated a mass measuring 48x37x55 mm, which<br />
occupied the entire right maxillary sinus, expanding to the orbit<br />
and the nasal pits. Inferiorly, the tumor eroded the upper alveolar<br />
arch, and was in contact with the masseter muscle (Fig. 1).<br />
The patient underwent surgical asportation and avulsion of the<br />
third upper right molar.<br />
At macroscopic examination, we found a non-ulcerated cystic<br />
mass with adherent thin bony plates within an impacted tooth<br />
and numerous vegetations adherent to the inner surface (Fig. 2).<br />
Histologically our case showed features of odontogenic cyst with<br />
associated areas of stellate reticulum with peripheral palisading<br />
as follicular or plexiform ameloblastoma and tumor islands with<br />
marked cellular atypia, hyperchromatism, nuclear pleomorphism,<br />
showing loss of peripheral palisading or nuclear polarity, increased<br />
mitotic index with 5 mitoses/10HPF (Fig. 3).<br />
Therefore our diagnosis was ameloblastic carcinoma arising from<br />
an odontogenic cyst.<br />
The patient has been followed for 12 months with CT scan of<br />
head and neck, chest radiograph, neck and abdominal ultrasonography,<br />
transnasal fibroendoscopy and CT-PET without evidence<br />
of local recurrences or metastatic localizations.<br />
references<br />
1 Lucca M, D’Innocenzo R, Kraus JA, et al. Ameloblastic carcinoma of<br />
the maxilla: a report of 2 cases. J Oral Maxillofac Surg 2010;68:2564-<br />
9.<br />
2 Yoon HJ, Hong SP, Lee JI, et al. Ameloblastic carcinoma: an analysis<br />
of 6 cases with review of the literature. Oral Surg Oral Med Oral<br />
Pathol Oral Radiol Endod 2009;108:904-13.<br />
3 Routray S, Majumdar S. Ameloblastic carcinoma: sometimes a challenge.<br />
J Oral Maxillofac Pathol <strong>2012</strong>;16:156-8.<br />
A feasibility evaluation on the dentist’s role for<br />
early diagnosis of oral cancer using a cost/effective<br />
innovative first level test with micro-biopsy<br />
R. Navone, S. Gandolfo1 , M. Pentenero1 , G. Tempia Valenta1 1 Dipartimento di Scienze Biomediche ed Oncologia Umana, Università<br />
di Torino; 1 Dipartimento di Scienze Cliniche e Biologiche, Sezione di<br />
Medicina ed Oncologia Orale, Università di Torino<br />
Background. Oral squamous carcinoma (OSCC) and pharyngeal<br />
cancer are amongst the most frequent malignant neoplasia (in 6th<br />
place for cancer-related death). Unfortunately, the last 30 years<br />
have not witnessed any significant improvement in survival rate,<br />
CONGRESSO aNNualE di aNatOmia patOlOGiCa SiapEC – iap • fiRENzE, 25-<strong>27</strong> OttOBRE <strong>2012</strong><br />
most likely due to this type of tumour often being diagnosed at<br />
an advanced stage. Moreover, the therapy required to deal with<br />
advanced stages leads to a highly compromised quality of life<br />
for the patient. Conversely, an early diagnosis has shown a high<br />
5-year survival rate (96.9%) (Pentenero et al., 2011). Noteworthy<br />
is the fact that numerous OSCC often arise on the site of precursor<br />
tumoural lesions (dysplasias) and their identification could<br />
well prevent their malignant transformation. The main obstacle<br />
facing an early diagnosis of OSCC is that this serious tumoural<br />
form and its precursors are easily confused with “clinically apparently<br />
innocent lesions” of inflammatory, traumatic or prosthetic<br />
origin, routine findings in the dentists’ every-day practise. When<br />
symptoms involving the oral mucosa appear the individual usually<br />
refers to his/her G.P., who, in turn, refers the patient to a<br />
dentist. That is why the dentist and G.P. are potentially able to<br />
carry out an effective prevention programme for an early OSCC<br />
diagnosis, as long as they have the necessary “know-how” to do<br />
so, including which tests to perform first and who to refer the patient<br />
to for a definitive diagnosis. The first of such tests available<br />
is the objective examination, which, although is surely necessary<br />
and efficacious, does not suffice, as it is not able to allow for a<br />
distinction between oral potentially malignant lesions (OPML)<br />
from lesions that will never evolve into cancer (Lingen et al.,<br />
2008). Therefore, the use of only an objective examination leads<br />
to the risk of underestimating OPML and/or early-stage cancer<br />
or, on the contrary, overestimating clinically apparently innocent<br />
lesions. First level tests have been proposed to diagnose the intraepithelial<br />
pre-invasive OPML that require scalpel (surgical)<br />
biopsy, but also, and above all, to identify those cases that do not,<br />
which are the majority. The requisites of a first level test include<br />
it not only being reliable and repeatable, but also user-friendly,<br />
even in non-expert hands, as well as it having a high sensitivity<br />
and specificity. To date, the dentist has had only one first level<br />
test at disposal i.e. oral cytology (Navone et al., 2007, 2011),<br />
which is not always easy to perform, has a low sensitivity and<br />
leads to a number of inadequate samples. There is, therefore, an<br />
evident need for a test with enhanced characteristics. The scalpel<br />
biopsy, today’s gold standard, is not a good first level test for the<br />
diagnosis of these lesions (Pentenero et al, 2003) as it is invasive<br />
and has sampling limits: it can be carried out only in restricted<br />
areas and on a limited number of sites and the identification of<br />
the most suitable sampling site is of no easy feat in non-expert<br />
hands. In fact, it may lead to false-negative results, even in the<br />
most expert of hands (Pentenero et al., 2003).<br />
A new sampling technique, called “micro-biopsy”, was developed<br />
by our team and data published (Navone et al., 2008). The<br />
technique involves scraping with a dermatological curette to<br />
obtain microhistological samples, rather than cytological ones. It<br />
is minimally invasive and has a high sensitivity (97.65%), a high<br />
negative predictive value (97.33%) and provides a high percentage<br />
of adequate samples. Although we proposed it be used as a<br />
first level test, before the data on this research project reported<br />
herein, we had no information as to the probability a dentist, nonexpert<br />
in oral mucosal pathology, has in obtaining samples of the<br />
same level. Therefore, this research was aimed at obtaining data<br />
on the capacity a dentist, who is not versed in the field, may have<br />
in the correct use of the micro-biopsy technique with the curette<br />
and to compare these data with those obtained by more expert<br />
hands. The research project was carried out in collaboration with<br />
free-lance dentists, with the aim of evaluating the adequacy of<br />
their sampling of the oral cavity mucosa lesions they came across<br />
in the course of their routine practise.<br />
Materials and methods. We carried out a prospective study<br />
financed by the Piedmont Region (Ricerca Sanitaria Finalizzata<br />
2008) in collaboration with A.N.D.I. (the National Italian Association<br />
of Dentists). A total of 75 free-lance dentists, working<br />
in the Torino area, were enrolled for a pre-training session on a<br />
voluntary basis, the only inclusion criteria was that they were